Identification of differentially expressed circular RNAs in chemoresistant colorectal cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of differentially expressed circular RNAs in chemoresistant colorectal cancer
Authors
Keywords
-
Journal
Epigenomics
Volume -, Issue -, Pages -
Publisher
Future Medicine Ltd
Online
2019-04-25
DOI
10.2217/epi-2019-0042
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Functional relevance of SATB1 in immune regulation and tumorigenesis
- (2018) Krishna P. Sunkara et al. BIOMEDICINE & PHARMACOTHERAPY
- Circular RNA circITGA7 inhibits colorectal cancer growth and metastasis by modulating the Ras pathway and upregulating transcription of its host gene ITGA7
- (2018) Xiaomin Li et al. JOURNAL OF PATHOLOGY
- A Study on Effect of Oxaliplatin in MicroRNA Expression in Human Colon Cancer
- (2018) Jasmine Evert et al. Journal of Cancer
- Circular RNA Signature Predicts Gemcitabine Resistance of Pancreatic Ductal Adenocarcinoma
- (2018) Feng Shao et al. Frontiers in Pharmacology
- Screening circular RNA related to chemotherapeutic resistance in osteosarcoma by RNA sequencing
- (2018) Zhu Kun-Peng et al. Epigenomics
- Expression and clinical significance of SATB1 and TLR4 in breast cancer
- (2017) Xuebo Wang et al. Oncology Letters
- Circular RNA hsa_circ_000984 promotes colon cancer growth and metastasis by sponging miR-106b
- (2017) Xiao-Wu Xu et al. Oncotarget
- Microarray Analysis of Circular RNA Expression Profile Associated with 5-Fluorouracil-Based Chemoradiation Resistance in Colorectal Cancer Cells
- (2017) Wei Xiong et al. Biomed Research International
- MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway
- (2017) Yuan Miao et al. Scientific Reports
- Understanding Cancer Drug Resistance by Developing and Studying Resistant Cell Line Models
- (2016) Cristina P.R. Xavier et al. CURRENT CANCER DRUG TARGETS
- Global patterns and trends in colorectal cancer incidence and mortality
- (2016) Melina Arnold et al. GUT
- The emerging role and clinical implication of human exonic circular RNA
- (2016) Dongbin Lyu et al. RNA Biology
- Circular RNAs as Promising Biomarkers: A Mini-Review
- (2016) Nadiah Abu et al. Frontiers in Physiology
- Up-regulation of miR-370-3p restores glioblastoma multiforme sensitivity to temozolomide by influencing MGMT expression
- (2016) Yong-tao Gao et al. Scientific Reports
- miRWalk2.0: a comprehensive atlas of microRNA-target interactions
- (2015) Harsh Dweep et al. NATURE METHODS
- Biogenesis, identification, and function of exonic circular RNAs
- (2015) Iju Chen et al. Wiley Interdisciplinary Reviews-RNA
- Predicting effective microRNA target sites in mammalian mRNAs
- (2015) Vikram Agarwal et al. eLife
- Serum miR-19a Predicts Resistance to FOLFOX Chemotherapy in Advanced Colorectal Cancer Cases
- (2014) Qi Chen et al. Asian Pacific Journal of Cancer Prevention
- SATB1 and 2 in colorectal cancer
- (2014) J. Brocato et al. CARCINOGENESIS
- miRDB: an online resource for microRNA target prediction and functional annotations
- (2014) Nathan Wong et al. NUCLEIC ACIDS RESEARCH
- Expression of SATB1 Promotes the Growth and Metastasis of Colorectal Cancer
- (2014) Yi Zhang et al. PLoS One
- In vitro Development of Chemotherapy and Targeted Therapy Drug-Resistant Cancer Cell Lines: A Practical Guide with Case Studies
- (2014) Martina McDermott et al. Frontiers in Oncology
- miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase
- (2013) Yunfei Zhou et al. Molecular Oncology
- High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer
- (2013) Mads H. Rasmussen et al. Molecular Oncology
- Establishment and biological characteristics of oxaliplatin-resistant human colon cancer cell lines
- (2012) Zhen Liu et al. Chinese Journal of Cancer
- Potential responders to FOLFOX therapy for colorectal cancer by Random Forests analysis
- (2011) S Tsuji et al. BRITISH JOURNAL OF CANCER
- Gene expression signature and response to the use of leucovorin, fluorouracil and oxaliplatin in colorectal cancer patients
- (2011) Toshiaki Watanabe et al. Clinical & Translational Oncology
- ToppGene Suite for gene list enrichment analysis and candidate gene prioritization
- (2009) J. Chen et al. NUCLEIC ACIDS RESEARCH
- Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer
- (2008) D. Cunningham et al. ANNALS OF ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started